• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Duration of penicillin prophylaxis in sickle cell anemia: issues and controversies.

作者信息

Pai V B, Nahata M C

机构信息

College of Pharmacy, Idaho State University, Boise, USA.

出版信息

Pharmacotherapy. 2000 Jan;20(1):110-7. doi: 10.1592/phco.20.1.110.34660.

DOI:10.1592/phco.20.1.110.34660
PMID:10641985
Abstract

Functional asplenia occurs in 94% of patients with homozygous sickle cell anemia by 5 years of age and may result in fatal septicemia due to encapsulated microorganisms such as Streptococcus pneumoniae. Penicillin prophylaxis in these patients significantly reduces the risk of septicemia; however, continuation of prophylaxis beyond 5 years of age is controversial, since the risk of developing septicemia is reduced after this age and prolonged prophylaxis may lead to emergence of penicillin resistance. Although reports of penicillin-resistant pneumococci in patients receiving penicillin prophylaxis are conflicting, the prevalence of these organisms in the general population in North America increased from 5% in 1989 to more than 35% in 1997. Discontinuation of prophylaxis after age 5 years may be recommended because of lack of benefit, difficulty maintaining compliance, reduced risk of developing pneumococcal bacteremia after that age, and increase in prevalence of penicillin-resistant pneumococci worldwide.

摘要

相似文献

1
Duration of penicillin prophylaxis in sickle cell anemia: issues and controversies.
Pharmacotherapy. 2000 Jan;20(1):110-7. doi: 10.1592/phco.20.1.110.34660.
2
Effect of penicillin prophylaxis on nasopharyngeal colonization with Streptococcus pneumoniae in children with sickle cell anemia.青霉素预防对镰状细胞贫血患儿肺炎链球菌鼻咽部定植的影响。
J Pediatr. 1984 Jan;104(1):18-22. doi: 10.1016/s0022-3476(84)80582-x.
3
Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II.青霉素预防对镰状细胞贫血患儿鼻咽部肺炎链球菌耐药性的影响。预防性青霉素研究II的辅助鼻咽培养研究
J Pediatr Hematol Oncol. 1997 Jul-Aug;19(4):327-33. doi: 10.1097/00043426-199707000-00011.
4
Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia.尽管接种了肺炎球菌疫苗并对镰状细胞贫血患儿进行了青霉素预防性用药,仍发生了肺炎球菌败血症。
Am J Dis Child. 1986 May;140(5):428-32. doi: 10.1001/archpedi.1986.02140190038020.
5
Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease.镰状细胞病患儿在青霉素预防时代的肺炎链球菌败血症和脑膜炎。
J Pediatr Hematol Oncol. 2002 Aug-Sep;24(6):470-2. doi: 10.1097/00043426-200208000-00012.
6
Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease.镰状细胞病患儿中耐抗生素肺炎链球菌的定植情况。
J Pediatr. 1996 Apr;128(4):531-5. doi: 10.1016/s0022-3476(96)70365-7.
7
Penicillin-resistant Streptococcus pneumoniae in a Jamaican patient with homozygous sickle-cell disease.一名患有纯合子镰状细胞病的牙买加患者体内的耐青霉素肺炎链球菌
West Indian Med J. 1996 Sep;45(3):95-6.
8
Prevalence of penicillin-nonsusceptible Streptococcus pneumoniae in nasopharyngeal cultures from patients with sickle cell disease.镰状细胞病患者鼻咽培养物中青霉素不敏感肺炎链球菌的患病率。
South Med J. 2001 Apr;94(4):401-4.
9
Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II.停止对镰状细胞贫血患儿进行青霉素预防治疗。预防性青霉素研究II。
J Pediatr. 1995 Nov;127(5):685-90. doi: 10.1016/s0022-3476(95)70154-0.
10
Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease.在患有镰状细胞病的儿童中,导致败血症和脑膜炎的耐青霉素和头孢菌素的肺炎链球菌菌株。
J Pediatr. 1995 Oct;127(4):526-32. doi: 10.1016/s0022-3476(95)70107-9.

引用本文的文献

1
Current modalities of sickle cell disease management.镰状细胞病的当前管理模式。
Blood Sci. 2020 Aug 27;2(4):109-116. doi: 10.1097/BS9.0000000000000056. eCollection 2020 Oct.
2
Pediatric Sickle Cell Disease in Sudan: Complications and Management.苏丹的儿童镰状细胞病:并发症与管理
Anemia. 2022 Feb 14;2022:3058012. doi: 10.1155/2022/3058012. eCollection 2022.
3
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.预防镰状细胞病患儿肺炎链球菌感染的预防性抗生素。
Cochrane Database Syst Rev. 2021 Mar 8;3(3):CD003427. doi: 10.1002/14651858.CD003427.pub5.
4
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.预防性使用抗生素预防镰状细胞病患儿的肺炎球菌感染。
Cochrane Database Syst Rev. 2017 Oct 10;10(10):CD003427. doi: 10.1002/14651858.CD003427.pub4.
5
Sickle cell disease.镰状细胞病
BMJ Clin Evid. 2016 Jan 22;2016:2402.
6
Penicillin prophylaxis in children with sickle cell disease.镰状细胞病患儿的青霉素预防治疗
J Pediatr Pharmacol Ther. 2010 Jul;15(3):152-9.
7
Pharmacological management of sickle cell disease.镰状细胞病的药物治疗
P T. 2008 Apr;33(4):238-43.